spacer
spacer

PDBsum entry 4zwz

Go to PDB code: 
protein ligands metals links
Lyase/lyase inhibitor PDB id
4zwz

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
257 a.a.
Ligands
510
DMS ×2
Metals
_ZN
Waters ×232
PDB id:
4zwz
Name: Lyase/lyase inhibitor
Title: Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
Structure: Carbonic anhydrase 2. Chain: a. Fragment: unp residues 4-260. Synonym: carbonate dehydratase ii,carbonic anhydrasE C,cac,carbonic anhydrase ii,ca-ii. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ca2. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.62Å     R-factor:   0.163     R-free:   0.211
Authors: B.P.Mahon,C.L.Lomelino,J.M.Driscoll,R.Mckenna
Key ref: B.P.Mahon et al. (2015). Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure-Activity Relationships of Glucosyl-Based Sulfamates. J Med Chem, 58, 6630-6638. PubMed id: 26203869 DOI: 10.1021/acs.jmedchem.5b00845
Date:
19-May-15     Release date:   05-Aug-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00918  (CAH2_HUMAN) -  Carbonic anhydrase 2 from Homo sapiens
Seq:
Struc:
260 a.a.
257 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 7 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.4.2.1.1  - carbonic anhydrase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: hydrogencarbonate + H+ = CO2 + H2O
hydrogencarbonate
+ H(+)
= CO2
+ H2O
      Cofactor: Zn(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1021/acs.jmedchem.5b00845 J Med Chem 58:6630-6638 (2015)
PubMed id: 26203869  
 
 
Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure-Activity Relationships of Glucosyl-Based Sulfamates.
B.P.Mahon, C.L.Lomelino, J.Ladwig, G.M.Rankin, J.M.Driscoll, A.L.Salguero, M.A.Pinard, D.Vullo, C.T.Supuran, S.A.Poulsen, R.McKenna.
 
  ABSTRACT  
 
Inhibition of human carbonic anhydrase IX (hCA IX) has shown to be therapeutically advantageous for treating many types of highly aggressive cancers. However, designing selective inhibitors for hCA IX has been difficult due to its high structural homology and sequence similarity with off-target hCAs. Recently, the use of glucosyl sulfamate inhibitors has shown promise as selective inhibitors for hCA IX. In this study, we present five X-ray crystal structures, determined to a resolution of 1.7 Å or better, of both hCA II (a ubiquitous CA) and an engineered hCA IX-mimic in complex with selected glucosyl sulfamates and structurally rationalize mechanisms for hCA IX selectivity. Results from this study have allowed us, for the first time, to empirically "map" key interactions of the hCA IX active site in order to establish parameters needed to design novel hCA IX selective inhibitors.
 

 

spacer

spacer